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Abstract: The state of Qatar suffers from diabetes epidemic due to obesity-associated metabolic
syndrome. However, the prevalence of insulin resistance prior to obesity, which could play an
important role in the high prevalence of diabetes, has not yet been described. This study aims to
compare the prevalence of insulin resistance in apparently healthy non-obese and obese participants
from Qatar and identify the predictors of insulin resistance in different body mass index (BMI)-groups.
In this cross-sectional study, 150 young healthy females from Qatar were dichotomized into four
groups (underweight, normal weight, overweight and obese) based on their BMI. Anthropometric
measures as well as fasting plasma levels of lipids, adipokines, blood glucose and insulin were
recorded. The prevalence of insulin resistance as per homeostatic model assessment of insulin
resistance (HOMA-IR) was estimated and differences between insulin sensitive and insulin resistant
were compared. Linear models were used to identify predictors of insulin resistance in every BMI
group. Prevalence of insulin resistance in non-obese healthy females from Qatar ranges between 7%
and 37% and increases with BMI. Overall, predictors of insulin resistance in the Qatari population are
triglycerides/high-density lipoprotein (HDL) ratio and free fat mass but vary according to the BMI
group. The main predictors were triglycerides in normal weight, triglycerides/HDL in overweight
and triglycerides/HDL and interleukin-6 (IL-6) in obese individuals. The high prevalence of insulin
resistance in non-obese Qataris may partially explain diabetes epidemic. Larger studies are warranted
to confirm these findings and identify underlying causes for insulin resistance in non-obese individuals
in Qatar, aiming at targeted intervention before diabetes onset.
Keywords: non-obese; insulin resistance; prevalence; BMI; Qatar
1. Introduction
The global prevalence of diabetes among adults of 20–79 years of age has risen from 4.7% in 1980
to 8.8% (95% confidence interval 7.2%–11.3%) in 2017 [1]. The epidemiologic transition to sedentary
lifestyle has contributed significantly to this epidemic, especially in the developing countries and
among certain ethnicities [2]. Qatar is a clear example of such a transition as a healthy life style (pearl
hunting and sea food-diet) has dramatically changed in the past 5 decades as the country’s economy
has become mostly dependent on gas and oil [3,4]. The overall prevalence of type II diabetes (T2D)
among adult Qatari population is currently alarmingly high (23.3%) with greater propensity among
women [5].
The association between insulin resistance and obesity is well established [6], however various
studies have shown that individuals with normal body weight can also become insulin resistant (IR) and,
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if left untreated, may eventually develop T2D and cardiovascular disease despite being non-obese [7–9].
Available evidence suggests that people with a body mass index (BMI) between 20 and 27 kg/m2
who have gained 2–10 kg of fat mass during adulthood constitute perfect candidates to develop
insulin resistance and subsequently T2D with risk factors including central fat distribution, inactivity
and a low maximum oxygen uptake (VO2max) [9]. Since these factors are potentially reversible
by controlling diet, exercise and possibly through pharmacological intervention, understanding the
pathophysiology of insulin resistance in non-obese individuals may offer a better chance for treating
insulin resistance before development of T2D with potentially irreversible consequences. Studies have
shown that long-term (5–6 years) diet and exercise can diminish T2D incidence in lean/overweight
subjects with impaired glucose tolerance [9]. Additionally, lean-IR individuals tend to be younger as
obesity increases with age; hence they are potentially more responsive to diet and exercise than their
older obese counterparts. Based on this evidence, targeted therapies aimed at young lean individuals
with insulin resistance could prevent the development of T2D and other diseases, including perhaps
obesity itself.
In order to improve the identification of insulin resistance in healthy individuals, many studies
have investigated the utility of various surrogate markers of insulin resistance. One study compared
the use of triglycerides/glucose against triglyceride/high-density lipoprotein (TG/HDL) cholesterol ratio
as potential surrogate markers. The study identified that both estimates correlated with steady-state
plasma glucose concentration to a similar degree with comparable associations to estimates using
fasting insulin [10]. Another study set to evaluate the association between TG/HDL ratio and insulin
resistance or hyperinsulinemia after oral glucose tolerance test (OGTT) in normal-weight healthy
adults. The study showed that high TG/HDL ratio was indeed associated with both insulin resistance
markers [11]. Similarly, the association between elevated triglycerides/glucose index (TGI) and insulin
resistance or hyperinsulinemia after oral glucose tolerance test (OGTT) revealed that elevated TGI was
associated with insulin resistance in healthy adults. The study suggested that the simplicity of the TGI
calculation makes it the first alternative when the hyperinsulinemic–euglycemic clamp or homeostatic
model assessment of insulin resistance (HOMA-IR) are not available [12].
Despite the high prevalence of diabetes in the Qatari population, the prevalence of insulin
resistance among non-obese apparently healthy individuals who belong to different BMI groups and
the potential predictors remain to be investigated. In this study, we aim to determine the prevalence of
insulin resistance in non-obese healthy young females from Qatar and identify the best predictors of
insulin resistance for diagnostic/therapeutic implications before the onset of diabetes.
2. Methods
2.1. Participants
One hundred and fifty healthy young (22.4 ± 4.6 years old) females with a range of BMI
(24.3 ± 5.3 kg/m2) were recruited at Qatar University campus. Students were selected through posters
and advertisements in social media. Protocols were approved by the Institutional Review Board
of Qatar University (QU-IRB 383-A/14) and were carried out in accordance with the Declaration
of Helsinki as revised in 2008. A consent form to participate in the study was obtained from each
participant. The study targeted university students to investigate the prevalence and mediators of
insulin resistance in age-matched groups.
2.2. Anthropometric and Biochemical Measurements
Weight and body composition were determined using body composition analyzer (Inbody 720,
Inbody, Cerritos, CA, USA). Height was measured by a stadiometer (Seca, Hamburg, Germany).
Waist circumference was determined using a meter tape (Seca, Hamburg, Germany). Blood samples
were obtained after overnight fasting from each participant. Fasting glucose, total cholesterol (TC),
triglycerides (TG) and high-density lipoprotein cholesterol (HDL-C) were assayed by routine automated
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laboratory methods at the clinical chemistry laboratories at Hamad Medical Corporation (HMC) using
Hitachi-917 (Gmbh Diagnostic, Mannheim, Germany). Insulin was determined by Elisa kit (Mercodia
Insulin ELISA, Uppsala, Sweden), IL-6 (Interleukin-6 High Sensitivity Human ELISA Kit, Abcam,
USA), adipokines ELISA Kits (R&D Systems, Minneapolis, USA) and TNF-alpha (Human TNF-alpha
Quantikine ELISA Kit, R&D Systems, Minneapolis, USA). Insulin resistance was calculated by
HOMA-IR [1] with 1.85 as a cut-off point (75th percentile) [2], accordingly samples were divided into
insulin sensitive (IS) and IR groups.
2.3. Statistical Analysis
Comparisons were performed using a t test, Wilcoxon–Mann–Whitney test, one-way ANOVA
or stepwise linear regression model as appropriate using IBM SPSS statistics 21 (Armonk, NY, USA).
Non-parametric tests were used for comparing ordinal or non-normal variables. Orthogonal partial
least square discriminant analysis (OPLS-DA) was employed to identify components that separate
insulin sensitive (IS) and IR groups. The model was run using SIMCA 14 including samples with
less than 50% missing metabolite values. Linear models for association analysis were run using the
R statistical package version 2.14, (www.r-project.org/). A receiver operating characteristic (ROC)
analysis was conducted using SPSS statistics 21 to evaluate the ability of the identified predictors of
HOMA-IR described in Table 3 to correctly discriminate between IR and IS groups. The ROC curves
for the established model were made and the overall diagnostic accuracy was quantified using the
area under the ROC curve (AUC). The optimal cut-off points were determined by the Youden’s index,
and the corresponding sensitivity and specificity were calculated. Significance was defined as p ≤ 0.05.
3. Results
3.1. General Characteristics and Prevalence of Insulin Resistance in Age-Matched Individuals with Different
BMI Groups
Participants were dichotomized into IS and IR based on HOMA-IR. General characteristics of
the study population are shown in Table 1. Results indicated that IR participants had higher BMI,
body fat mass, % fat mass, waist circumference and waste to height ratio (WHtR) than age-matched IS
counterparts. There was no significant difference in blood glucose between IR and IS. The prevalence
of insulin resistance was 22.7% among the study population and it increased with BMI. The lowest
prevalence was observed among underweight participants (7.1%) and the highest rate was for obese
(45%). In all groups, the difference in HOMA-IR was mostly related to insulin levels as they had similar
glucose levels. Furthermore, IR participants showed higher TG (0.96 ± 0.43 vs. 0.74 ± 0.23, p < 0.001),
TG/HDL ratio (0.82 ± 0.54 vs. 0.56 ± 0.25, p < 0.001), LDL oxidase (23.5 ± 4.7 vs. 21.2 ± 4.4, p = 0.03)
but lower adiponectin (21.1 ± 7.1 vs. 16.6 ± 6.3, p = 0.01), than their IS counterparts. When comparing
lipids, and adipokines between IS and IR in various BMI groups (Table 2), TG was found higher
in normal weight IR compared to IS counterparts, whereas Apolipoprotein A (ApoA) was lower in
normal weight IR compared to normal weight IS. Adiponectin was higher in overweight IS compared
to overweight IR. TG/HDL ratio was higher in obese IR compared to obese IS. IL-6 was lower in normal
weight IR compared to normal weight IS, so was TNF-alpha in overweight IR compared to overweight
IS. None of the other lipids or adipokines were significantly different between the IS and IR in BMI
groups (Table 2). As expected, the percentage of participants with fasting blood glucose above 6.1 mM
increased with BMI (0% in underweight, 2.4% in normal weight, 2.9% in overweight and 5% in obese).
In addition, the percentage of women with HDL levels lower than 2 mM were highest in overweight
(22.9%) and obese (35%) compared to underweight (0%) and normal weight (7.3%). Surprisingly,
the percentage of women with total cholesterol levels above 5.2 mM was higher in underweight (14.3%)
and normal weight (14.6%) compared to overweight (2.9%) and obese (10%).
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Table 1. General characteristics of study participants divided into underweight, normal weight, overweight and obese insulin sensitive (IS) and insulin resistant
(IR) participants.
Groups Combined Under Weight Normal Weight Overweight Obese
(116 IS and 34 IR) (13 IS and 1 IR) (71 IS and 11 IR) (22 IS and 13 IR) (11 IS and 9 IR)
Characteristics (IR Prevalence 22.7%) (IR Prevalence 7.1%) (IR Prevalence 13.4%) (IR Prevalence 37.1%) (IR Prevalence 45%)
Mean SD p Value Mean SD Mean SD p Value Mean SD p Value Mean SD p Value
Age (years) IS 22.5 4.9 0.449
21.4 1.7 22.4 5.1
0.938
23.4 5.6
0.551
23.1 4.8
0.237IR 21.8 3.6 18 N/A 22.3 5.3 22.4 3.5 21.1 1.4
BMI (Kg/m2)
IS 23.5 4.6
<0.001
17.3 0.9 21.9 2
0.946
27.1 1.3
0.424
33.2 3.2
0.184IR 28 5.8 18 N/A 21.8 1.5 27.5 1.6 35.2 3.3
Body fat mass IS 21.5 8.8 <0.001
10.3 2.5 18.6 4.2
0.998
27.8 4.1
0.628
40 6
0.391IR 29.5 11.1 12.1 N/A 18.6 4.9 28.4 3.8 42.7 8.1
WC (cm) IS 81.6 10 <0.001
70.3 6.3 78.8 7.2
0.694
89.4 7.1
0.491
95.9 7.3
0.013IR 90.6 13 87 N/A 77.8 8.9 87.9 4 106.3 9.5
Total body water IS 28.8 5.6 0.366
24.7 2 28.5 6.5
0.048
30.4 2.9
0.171
31.9 3
0.163IR 29.7 4.1 27.7 N/A 26.3 1.8 29 2.8 34.1 3.9
Free fat mass
IS 20.7 3.1
0.037
17.8 1.7 20.1 2.8
0.309
22.6 2.4
0.216
23.7 2.4
0.149IR 22 3.4 20.2 N/A 19.1 1.5 21.5 2.2 25.5 3.2
% body fat IS 34.6 7.8 <0.001
23.2 4.1 32.9 5.3
0.713
39.9 4.2
0.236
47.8 2.8
0.696IR 41 7.6 24.2 N/A 33.7 4.8 41.7 4.1 48.4 4.2
WHtR
IS 0.5 0.1
<0.001
0.4 0 0.5 0.1
0.811
0.6 0
0.866
0.6 0
0.029IR 0.6 0.1 0.5 N/A 0.5 0.1 0.6 0 0.7 0.1
Glucose (mmol/L) IS 5 0.4 0.581
5 0.3 5 0.4
0.912
5 0.4
0.059
4.9 0.5
0.259IR 5 0.6 5.1 N/A 5.1 0.4 4.7 0.5 5.2 0.7
Insulin (pmol/L) IS 2.8 2.2 <0.001
2.4 2.5 2.4 2.1
<0.001
4 2.2
<0.001
3.2 1.8
<0.001IR 20.3 7.8 20.9 N/A 20.8 7.3 18.9 7.2 21.9 9.8
HOMA-IR
IS 0.6 0.5
<0.001
0.5 0.5 0.5 0.5
<0.001
0.9 0.5
<0.001
0.7 0.4
<0.001IR 4.5 1.7 4.7 N/A 4.6 1.5 4.1 1.8 4.9 2
Results are presented as mean and SD. BMI body mass index, WC waist circumference, WHtR waist to height ratio, HOMA-IR homeostatic model assessment of insulin resistance.
Differences between IS and IR were tested by an independent sample t test (normally distributed variables) or Mann–Whitney U (variables with skewed distribution) test. A p-value
significance level of 0.05 was used.
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Table 2. Profiles of lipids and adipokines in underweight, normal weight, overweight and obese insulin sensitive (IS) and insulin resistant (IR) participants.
Groups Combined Under Weight Normal Weight Overweight Obese
Characteristics Mean SD p Value Mean SD Mean SD p Value Mean SD p Value Mean SD p Value
LDL (mmol/L) IS 2.4 0.7 0.123
2.2 0.7 2.5 0.7
0.102
2.4 0.4
0.486
2.4 0.9
0.998IR 2.2 0.5 1.8 N/A 2.1 0.5 2.2 0.5 2.4 0.6
HDL (mmol/L) IS 1.4 0.3 0.049
1.6 0.4 1.5 0.4
0.867
1.3 0.3
0.581
1.2 0.2
0.427IR 1.3 0.4 1.5 N/A 1.4 0.3 1.2 0.4 1.1 0.2
Triglyceride (mmol/L) IS 0.7 0.2 <0.001
0.7 0.2 0.7 0.2
0.027
0.8 0.2
0.159
0.8 0.3
0.115IR 1.0 0.4 0.7 N/A 0.9 0.4 1.0 0.5 1.0 0.3
Cholesterol (mmol/L) IS 4.2 0.9 0.147
4.2 1.0 4.3 0.9
0.288
4.0 0.6
0.694
3.9 1.0
0.972IR 3.9 0.7 3.6 N/A 4.0 0.8 3.9 0.7 3.9 0.8
APoA (g/L) IS 0.6 0.7 0.494
0.6 0.5 0.5 0.6
0.204
0.9 0.9
0.673
0.7 0.4
0.372IR 0.7 0.7 0.4 N/A 0.3 0.2 1.0 1.0 0.9 0.6
LDL oxidase
IS 21.2 4.4
0.031
20.4 3.2 21.8 4.0
0.625
20.1 6.1
0.218
20.6 3.1
0.174IR 23.5 4.7 27.2 N/A 22.6 3.2 22.7 3.4 25.2 7.7
Leptin (ng/mL) IS 3.4 1.5 0.262
4.2 1.6 3.6 1.5
0.169
2.5 1.0
0.077
4.1 1.9
0.987IR 3.8 1.4 4.8 N/A 4.3 1.1 3.1 1.2 4.1 1.7
Adiponectin (ng/mL) IS 21.1 7.1 0.01
23.9 6.7 22.8 7.4
0.991
20.2 7.0
0.03
17.8 6.2
0.952IR 16.6 6.3 N/A N/A 22.7 1.0 14.8 5.6 17.6 7.0
CRP (mg/L) IS 2.4 2.7 0.077
2.1 2.6 1.7 2.3
0.744
3.4 2.7
0.957
4.5 3.9
0.726IR 3.3 3.0 1.2 N/A 2.0 2.8 3.4 3.0 5.1 2.9
IL-6 (pg/mL) IS 3.0 3.5 0.758
2.9 1.7 2.7 1.9
0.167
2.7 1.0
0.147
6.2 9.8
0.359IR 2.8 1.2 4.6 N/A 1.9 0.7 3.3 1.3 3.1 0.9
TNFalpha (pg/mL) IS 119.8 273.2 0.665
33.2 13.8 148.8 314.7
0.582
127.5 290.9
0.594
42.9 47.7
0.332IR 92.3 203.9 N/A N/A 22.5 5.7 76.4 199.1 129.2 238.1
Results are presented as mean and SD. Low density lipoprotein (LDL), High density lipoprotein (HDL), Apo lipoprotein A (ApoA), Differences between IS and IR were tested by an
independent sample t test (normally distributed variables) or Mann–Whitney U (variables with skewed distribution) test. A p-value significance level of 0.05 was used.
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3.2. Multivariate Analysis of Mediators of the Metabolic Syndrome
An orthogonal partial least square discriminate analysis (OPLS-DA) comparing mediators of
the metabolic syndrome between IS and IR subjects was used for ease of visualization. The model
revealed two class-discriminatory components accounting for 61.5% of the variation in the data due to
participants’ group (Figure 1). The score plot in Figure 1A shows an x-axis separating IS and IR groups
and y-axis that clearly separated the BMI groups. The loading plot in Figure 1B shows mediators of
metabolic syndrome that were responsible for separating the IS and IR groups on the x-axis including
insulin and HOMA-IR on the IR end and HDL and adiponectin on the IS end. The loading plot
also shows mediators of metabolic syndrome that best separated BMI groups including HDL and
adiponectin in the underweight end and body mass index (BMI), waist to hip ratio (WHR), body fat
percentage BFP and waist circumference (WC) in the obese end.
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Figure 1. Orthogonal partial least square discriminate analysis (OPLS-DA) model comparing mediators
of metabolic disease in IS and IR participants. (A). A score plot showing the class-discriminatory
component 1 (x-axis) versus orthogonal component (y-axis). (B). An updated score plot that reveals
that the orthogonal component (y-axis) mostly represent BMI groups (underweight, normal weight,
overweight and obese). (C). The corresponding loading plot showing mediators of metabolic syndrome
at either ends of the discriminatory components along the x-axis and y-axis.
3.3. Mediators of Insulin Resistance
A generalized linear model was performed to identify mediators that best explain variance in
HOMA-IR irrespective of BMI. As expected, the model identified TG, IL-6, adiponectin, HDL and
TNF-alpha as top variables explaining HOMA-IR with TG exhibiting highest impact (66.4%) whereas
TNF-alpha showing the least (0.8%; Table 3). A follow-up stepwise linear regression model identified
TG/HDL ratio and free fat mass to best predict insulin resistance irrespective of BMI. Within the BMI
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groups, TG, TG/HDL and TG/HDL + IL-6 were the best predictors of insulin resistance in normal
weight, overweight and obese subjects respectively (Table 4, Figure 2).
Table 3. Variables explaining HOMA-IR by generalized linear model.
Variables Explaining HOMA-IR Importance p Value
Triglycerides 0.67 <0.001
Interleukin-6 0.29 <0.001
Adiponectin 0.03 <0.001
HDL 0.01 <0.001
TNF-alpha 0.008 <0.001
Table 4. Predictors of HOMA-IR in normal weight, overweight and obese groups by stepwise linear
regression followed by the receiver operating characteristic (ROC) curve.
Group Predictor
Adjusted Std. Error of
the Estimate
p Value Area Under Curve (95% CI)R Square
Normal weight TG 0.23 1.2 0.01 0.61 (0.41–0.81)
Overweight TG/HDL 0.22 1.3 0.01 0.66 (0.47–0.85)
Obese TG/HDL 0.44 2 0.01 0.78 (0.57–0.99)
All groups
TG/HDL 0.31 1.4 <0.001 0.7 (0.60–0.80)
TG/HDL and
Free fat mass 0.37 1.4 0.02 0.68 (0.57–0.79)
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4. Discussion
Pre-diabetes represents a transitional state of hyperglycemia as resistance to insulin becomes above
normal but below the diabetes threshold. Although criteria used for diagnosis of pre-diabetes vary
among different studies, pre-diabetes constitutes an increased risk for developing diabetes at an annual
rate of 5%–10% [4]. The association between pre-diabetes and various diabetes complications such
as early nephropathy, small fiber neuropathy, early retinopathy and a risk of macrovascular disease
is well established [5]. Lifestyle interventions were shown to reduce diabetes incidents 40%–70%
in adults with pre-diabetes [4]. Results from a 12-month life style intervention program targeting
obese with prediabetes revealed that 37% of participants did not show any criteria of prediabetes
after the intervention. The dietary intervention consisted of lower energy dense foods and foods with
high glycemic index [6]. A recent meta-analysis reported a 36% reduction in the risk of developing
diabetes among prediabetes enrolled in life style intervention [3]. Despite this information, systematic
evaluation of pre-diabetes in the general population is still lacking.
The prevalence of T2D is particularly high among certain ethnicities such as South Asians, Middle
Eastern and Africans at a lower BMI and younger age compared to Caucasians [7]. The state of Qatar
has suffered from a diabetes epidemic in the past few decades. This epidemic was attributed mainly
to the high prevalence of obesity that resulted from a sudden transition from active to sedentary
lifestyle following the discovery of gas and oil [8]. Although the rise in insulin resistance in non-obese
individuals could also explain the high prevalence of diabetes in this population, it has not yet been
addressed. In this study, prevalence of insulin resistance measured by HOMA-IR was investigated
in age-matched young females from Qatar who belong to different BMI groups. The novel findings
reported here indicate a high prevalence of insulin resistance prior to onset of obesity and identifies
predictors of insulin resistance in different BMI groups.
Several studies have identified IR individuals using the gold-standard hyperinsulinemic–
euglycemic clamp technique [9,10]. However, this technique is invasive, expensive as well as time
consuming. Therefore, other methods have been used to identify IR individuals, such as the Matsuda
index [11], an oral glucose tolerance test derived index and the HOMA-IR [12], a fasting surrogate
index. The latter index has been also combined with clinical criteria to identify IR individuals [13].
Furthermore, several studies have defined IR individuals based on the extremes of insulin (that is,
upper quartiles or lower tertiles) [1,14]. Other factors such as age and sex were also reported to affect
IR prevalence. For example, the prevalence of IR individuals is lower in younger individuals of the
metabolically healthy obese Italian individuals particularity in women [15]. However, caution should
be taken when considering the prevalence of IS subjects in these studies as numbers could be simply a
reflection of the predefined selection criteria and the stringency used to detail the phenotype. Despite
its crude nature, HOMA-IR was used in this study to dichotomize participants into IS and IR using
1.85 as a cut-off point (75th percentile) [2], because of its non-invasive nature and better compliance.
In this study, there was a positive correlation between HOMA-IR and BMI (R2 = 0.3, p = 0.001).
Although expected, the increase in insulin resistance with BMI was surprisingly high in the overweight
(37.1%) and obese (45%) groups. Previous studies in other ethnicities have reported that around 25% of
overweight individuals were insulin resistant [16–18]. The high prevalence of insulin resistance seen in
this population compared to previous reports may partially explain the high incidents of diabetes [19].
Previous studies have indicated that insulin resistance could predict up to 80% of increased risk of
diabetes among non-obese persons [18], which in this population may suggest that almost 30% of
overweight participants could develop T2DM. This high risk of diabetes among this seemingly healthy
young group constitutes a challenge to the local authorities as it poses a high burden on health services
because of associated morbidities and all-cause mortality including risk of cardiovascular disease [20].
Hence, identifying best predictors of insulin resistance could provide important tools for screening
programs aiming at targeted intervention before the onset of diabetes.
Our data indicated that variance in overall HOMA-IR was mainly explained by TG and IL-6.
However, when considering different BMI groups, predictors of insulin resistance varied. The main
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predictor of insulin resistance in the normal weight group was TG, although the predictive power was
lower than TG/HDL in other BMI groups as suggested by AUC in ROC. On the other hand, TG/HDL
was the best predictor of insulin resistance in overweight and obese groups. Similar to our findings,
previous reports have indicated that lean individuals with non-alcoholic fatty liver disease (NAFLD)
have higher HOMA-IR and lower serum adiponectin compared to overweight-without-NAFLD with
TG content being the most important determinant of insulin resistance [21]. Previous studies have also
indicated that TG/HDL and TG were significantly associated with insulin resistance in normal-weight
and overweight/obese Chinese women [22] and Taiwanese adults [23]. Other studies have also shown
that risk of metabolic syndrome was incrementally associated with TG/HDL with no consensual
cut-off values [24]. Our results confirmed the relationship between lipid and carbohydrate metabolism
disorders. In this model, hyperinsulinemia can develop against pre-existing lipid metabolism disorders
where lipid accumulation in skeletal muscle and liver could result from elevated delivery and synthesis
of fatty acids in these tissues when energy intake exceeds the storage capacity of adipose tissue
storage [25].
Study Limitations
This was an observational study with a relatively small number of participants, hence, results
need to be confirmed in a larger cohort. Additionally, the presence of the non-obese IR phenotype at a
young age confirms that models based solely on BMI may not be sensitive enough to detect insulin
resistance in this group. Some studies even indicated that certain non-obese individuals could be
considered obese based on the percentage of their body fat. [26,27], although this was not the case in
our young female group, perhaps because of ethnic or age differences. However, it is possible that
a subset of the non-obese IR individuals exhibit greater intramuscular fat deposition as previously
reported [28].
5. Conclusions
Pre-diabetes is a state of intermediate hyperglycemia. While there are several controversies about
the diagnosis of pre-diabetes, it remains an at-risk state for the development of diabetes. Several
adverse health outcomes have been associated with pre-diabetes. In this study, we highlighted the
high prevalence of insulin resistance in overweight young females from Qatar and identified TG
and TG/HDL ratio to be predict insulin resistance in this group. Preventive strategies will require
addressing modifiable risk behaviors, including lack of physical activity and dietary intake, aiming at
ameliorating risk of T2DM in this population.
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